New Materials Industry

In 2020, industrial enterprises above the designated size increased their added value by 8.4 percent year on year with an output value of more than RMB 660 billion. Fujian province boasts a production capacity of more than 15,000 tons of rare earth materials, including magnetic materials, hydrogen storage materials, and luminescent materials. Twenty-eight grapheme-related platforms have been built across the province. The production of LED products, hydrogen storage alloy materials for hybrid battery and laser crystals ranks among the top in China.

Biological & New Pharmaceutical Industry

In 2020, the added value of industrial enterprises above designated size rose by 0.3 percent year on year, and the output value of the industry exceeded RMB 60 billion. The technology of such protein drugs as recombinant human granulocyte-macrophage colony-stimulating factor and its market share took the lead in China. In addition, bio-pharmaceutical technologies such as an Escherichia coli-derived virus-like particle-based vaccine, a recombinant hepatitis E vaccine, and a recombinant human papillomavirus vaccine all held world leading positions.